Mixed Topics
Feature
New study of diabetes drug for COVID-19 raises eyebrows
Feature
Survey: Hydroxychloroquine use fairly common in COVID-19
Conference Coverage
COVID-19: No U.S. spike expected in pandemic-related suicidal ideation
Big Data analysis of real-time Crisis Text Line experience offers encouragement.
Conference Coverage
COVID-19: Calls to NYC crisis hotline soar
Inbound call volume has increased roughly 50% since the COVID-19 pandemic hit.
From the Journals
Consensus recommendations on AMI management during COVID-19
The ACC, ACEP, and SCAI recommend a systematic approach for the care of patients with an acute myocardial infarction during the COVID-19 pandemic...
News
Visa worries besiege immigrant physicians fighting COVID-19
Hospital leaders call for flexibility to keep immigrant physicians on the front lines of the COVID-19 battle.
Feature
COVID-19 decimates outpatient visits
FDA/CDC
FDA reiterates hydroxychloroquine limitations for COVID-19
An FDA Safety Communication restates that hydroxychloroquine and chloroquine are only for hospitalized COVID-19 patients who can’t enter a trial...
From the Journals
COVID-19: Experts call for ‘urgent’ global action to prevent suicide
An increase in suicide related to COVID-19 is not inevitable provided preventive action is prompt, the group notes.
From the Journals
Angiotensin drugs and COVID-19: More reassuring data
From the Journals
Hydroxychloroquine ineffective for COVID-19, VA study suggests
The retrospective study, which included